Estrogen and progesterone reduce lipid accumulation in human monocyte- derived macrophages: A sex-specific effect

Circulation

Volumn 100, Issue 23, 1999, Pages 2319-2325

  McCrohon, Jane A ^a   Nakhla, Shirley ^a   Jessup, Wendy ^a   Stanley, Keith K ^a,c   Celermajer, David S ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Atherosclerosis; Cells; Lipids; Lipoproteins

Indexed keywords

ESTRADIOL; IODINE 125; LOW DENSITY LIPOPROTEIN; PROGESTERONE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; HORMONE ACTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

EID: 0033534118     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.23.2319     Document Type: Article

References (47)

1. Wingard DL, Suarez L, Barrett-Connor E. The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol. 1983; 117:165-172.
2. Lerner DJ, Kannel WM. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham Study. Am Heart J. 1986;111:383-390.
3. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shicely CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88: 1995-2002.
4. Haarbo J, Nielsen LB, Stender S, Christiansen C. Aortic permeability to LDL during estrogen therapy: a study in normocholesterolemic rabbits. Arterioscler Thromb. 1994;14:243-247.
5. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
6. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328: 1069-1075.
7. Sacks FM, Walsh BW. The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice. Ann N Y Acad Sci. 1990;592:272-285.
8. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA. Estrogen improves endothelium-dependent, flow-mediated dilation in post-menopausal women. Ann Intern Med. 1994;121:936-941.
9. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75: 1102-1109.
10. Lee WS, Harder JA, Yoshizumi M, Lee ME, Haber E. Progesterone inhibits arterial smooth muscle cell proliferation. Nat Med. 1997;9: 1005-1008.
11. The Writing Group for the PEPI Trial. The Postmenopausal Estrogen/ Progestin Interventions (PEPI) trial. JAMA. 1995;273:199-208.
12. Gebara OCE, Mittleman MA, Sutherland P, Lipinska I, Matheny T, Xu P, Welty FK Wilson PWF, Levy D, Muller JEM, Tofler GH. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation. 1995;91:1952-1958.
13. Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation. 1998; 97:1234-1238.
14. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JA, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH, Speizer FE. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997;336:1769-1775.
15. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605-613.
16. Masuda J, Ross R. Atherogenesis during low level hypercholesterolemia in the non-human primate, I: fatty streak formation. Arteriosclerosis. 1990;10:164-177.
17. Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witzum JL. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins and contain oxidation-specific lipid-protein adducts. J Clin Invest. 1991;87:90-99.
18. Garner B, Dean RT, Jessup W. Human macrophage-mediated oxidation of low-density lipoprotein is delayed and independent of superoxide production. Biochem J. 1994;301:421-428.
19. Andreesen R, Brugger W, Scheibenbogen C, Kreutz M, Leser HG, Rehm A, Löhr GW. Surface phenotype analysis of human monocyte to macrophage maturation. J Leukoc Biol. 1990;47:490-497.
20. Brown MS, Goldstein JL, Krieger M, Ho YK, Anderson RGW. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J Cell Biol. 1979;82:597-613.
21. Contreras MA, Bale WF, Spar IL. Iodine monochloride (ICl) iodination techniques. Methods Enzymol. 1983;92:277-292.
22. Kritharides L, Jessup W, Dean RT. A method for staging the degree of LDL oxidation by the separation of cholesterol and cholesteryl ester oxidation products using HPLC. Anal Biochem. 1993;213:79-89.
23. Goldstein JL, Basu SK, Brown MS. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 1983;98: 241-260.
24. Munson J. A User's Guide to LIGAND: Data Analysis and Curve-Fitting for Ligand-Binding Experiments. Bethesda, Md: National Institutes of Health; 1993.
25. Sulistiyani, St Clair RW. Effect of 17β-estradiol on metabolism of acetylated low-density lipoprotein by THP-1 macrophages in culture. Arterioscler Thromb Vasc Biol. 1997;17:1691-1700.
26. Burgess JW, Stanley KK. 17β-Ethynylestradiol increases transcytosis of asialoglycoproteins in rat liver. J Biol Chem. 1994;269:3482-3488.
27. Dunn KW, Maxfield FR. Delivery of ligands from sorting endosomes to late endosomes occurs by a maturation of sorting endosomes. J Cell Biol. 1992;117:301-310.
28. Warren RA, Green FA, Enns CA. Saturation of the endocytic pathway for the transferrin receptor does not affect the endocytosis of the epidermal growth factor receptor. J Biol Chem. 1997;272:2116-2121.
29. Davis CG, Goldstein JL, Südhof TC, Anderson RGW, Russell DW, Brown MS. Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region. Nature. 1987;326: 760-765.
30. Zhang H, Yang Y, Steinbrecher UP. Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages. J Biol Chem. 1993;268:5535-5542.
31. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest. 1996;98:36-42.
32. Caulin-Glaser T, Farrell W, Pfau SE, Zaret B, Bunger K, Setaro JF, Brennan JJ, Bender JR, Cleman MW, Cabin HS, Remetz MS. Modulation of circulating cell adhesion molecules in postmenopausal women with coronary artery disease. J Am Coll Cardiol. 1998;31:1555-1560.
33. Hanke H, Hanke S, Finking G, Muhic-Lohrer A, Mück AO, Schmahl FW, Haasis R, Hombach V. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits: quantification of cellular proliferation by bromodeoxyuridine. Circulation. 1996;94: 175-181.
34. Bruck B, Brehme U, Gugel N, Hanke S, Finking G, Lutz C, Benda N, Schmahl FW, Haasis R, Hanke H. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 1997;17:2192-2199.
35. Van Dyke RW, Root KV. Ethinyl estradiol decreases acidification of rat liver endocytic vesicles. Hepatology. 1993;18:604-613.
36. Mazzone T, Krishna M, Lange Y. Progesterone blocks intracellular translocation of free cholesterol derived from cholesterol ester in macrophages. J Lipid Res. 1995;36:544-551.
37. Lange Y. Cholesterol movement from plasma membrane to rough endoplasmic reticulum. J Biol Chem. 1994;269:3411-3414.
38. Doi T, Higashino K, Kurihara Y, Wada Y, Miyazaki T, Nakamura H, Uesugi S, Imanishi T, Kawabe Y, Itakura H, Yazaki Y, Matsumoto A, Kodama T. Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem. 1993;268:2126-2133.
39. Gerrity RG. The role of the monocyte in atherogenesis, I: transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181-190.
40. Aquel NM, Ball RY, Waldmann H, Mitchinson MJ. Monocytic origin of foam cells in atherosclerotic plaques. Atherosclerosis. 1984;53:265-271.
41. Tsuchiya S, Kobayashi Y, Goto Y, Okomura H, Nakai S, Kono T, Taka K. Induction of maturation in cultured human monocytic leukaemia cell lines by a phorbol diester. Cancer Res. 1982;42:1530-1536.
42. Auwerx J. The human leukaemia cell line, THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia. 1991; 47:22-31.
43. Danel L, Souweine G, Monier JC, Saez S. Specific estrogen binding sites in human lymphoid cells and thymic cells. J Steroid Biochem. 1983;18: 559-563.
44. Cutolo M, Accardo S, Villagio B, Barone A, Sulli A, Coviello D, Carrabio C, Felli L, Miceli D, Farrugio R, Carruba G, Castagnetta L. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab. 1996;81: 820-827.
45. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Müller KH, Sharkey AM, Smith SK. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest. 1996;98:482-489.
46. Kamps JA, Kruijit J, Kuiper J, van Berkel TJC. Characterization of the interaction of acetylated LDL and oxidatively modified LDL with human liver parenchyma and Kupffer cells in culture. Arterioscler Thromb. 1992;12:1079-1087.
47. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiuchi S, Takahashi K, Kruijit JK, van Berkel TJC, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, Kodama T. A role for scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997; 386:292-296.